Kaye Edward M. MD sold STOK
September 3, 2025 · Form 4 insider transaction
Kaye Edward M. MD sold 45,996 shares of Stoke Therapeutics, Inc. at $20.13 per share, a transaction worth $925.9K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Disposed (sell-side)
Shares
45,996
Price
$20.13
Total value
$925.9K
InsiderKaye Edward M. MD
RoleDirector
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateSeptember 3, 2025
Filing dateSeptember 3, 2025
Shares owned after91,585
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 30, 2024.; The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.00 to $20.40, inclusive.